|
MARCH6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.53459999999917E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.54030000002015E-06 |
| Normal-vs-Stage2 |
1.633980E-01 |
| Normal-vs-Stage3 |
1.018850E-01 |
| Normal-vs-Stage4 |
2.223200E-01 |
| Stage1-vs-Stage2 |
2.939200E-01 |
| Stage1-vs-Stage3 |
2.405200E-01 |
| Stage1-vs-Stage4 |
5.005600E-01 |
| Stage2-vs-Stage3 |
9.849400E-01 |
| Stage2-vs-Stage4 |
9.230400E-01 |
| Stage3-vs-Stage4 |
9.316400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.81829999999339E-05 |
| Normal-vs-AfricanAmerican |
3.166700E-04 |
| Normal-vs-Asian |
4.080600E-03 |
| Caucasian-vs-AfricanAmerican |
6.530200E-01 |
| Caucasian-vs-Asian |
5.639200E-01 |
| AfricanAmerican-vs-Asian |
6.501000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.50569999971084E-07 |
| Normal-vs-Female |
4.171200E-01 |
| Male-vs-Female |
2.104100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.141600E-02 |
| Normal-vs-Extreme_Weight |
3.43410000003264E-06 |
| Normal-vs-Obese |
2.381500E-03 |
| Normal-vs-Extreme_Obese |
7.021100E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.592410E-01 |
| Normal_Weight-vs-Obese |
8.470200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.485800E-01 |
| Extreme_Weight-vs-Obese |
1.251550E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.040200E-01 |
| Obese-vs-Extreme_Obese |
2.460000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.239000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.255640E-02 |
| Normal-vs-Age(61-80Yrs) |
1.81280000011164E-07 |
| Normal-vs-Age(81-100Yrs) |
7.411500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.618200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.225810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.904830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.921300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.531600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.054200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.68110000031696E-07 |
| Normal-VS-Type2 PRCC |
1.367550E-02 |
| Normal-VS-KIRP CIMP |
6.983600E-01 |
| Normal-VS-Unclassified PRCC |
2.473600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.752000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.284300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.385900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.287600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.288000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.319000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.216660E-04 |
| Normal-vs-N1 |
3.303000E-01 |
| Normal-vs-N2 |
9.102800E-01 |
| N0-vs-N1 |
8.193700E-02 |
| N0-vs-N2 |
2.584400E-01 |
| N1-vs-N2 |
8.009400E-01 |
|
|
